{"gao_id": "GAO-11-744", "published": "2011-08-26T12:00:00Z", "released": "2011-09-26T08:00:00Z", "summary": "", "title": "Prescription Drug Control: DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results", "topics": ["Substance abuse", "Internal controls", "Physicians", "Controlled substances", "Policies and procedures", "Justice and Law Enforcement", "Investigations by federal agencies", "Law enforcement", "Pharmaceutical industry", "Prescription drugs", "Manufacturing industry", "Performance measures"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-11-744", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-11-744-highlights.pdf"}, {"title": "Full Report (55 pages)", "url": "https://www.gao.gov/assets/gao-11-744.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/520/511465.txt"}]}